NO20073664L - Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet - Google Patents

Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet

Info

Publication number
NO20073664L
NO20073664L NO20073664A NO20073664A NO20073664L NO 20073664 L NO20073664 L NO 20073664L NO 20073664 A NO20073664 A NO 20073664A NO 20073664 A NO20073664 A NO 20073664A NO 20073664 L NO20073664 L NO 20073664L
Authority
NO
Norway
Prior art keywords
neuropeptide
receptor
peptides
agonist activity
obesity
Prior art date
Application number
NO20073664A
Other languages
English (en)
Norwegian (no)
Inventor
Waleed Danho
Joseph Swistok
George Erlich
David C Fry
Wajiha Khan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20073664L publication Critical patent/NO20073664L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57545Neuropeptide Y
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20073664A 2005-01-18 2007-07-17 Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet NO20073664L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64484005P 2005-01-18 2005-01-18
PCT/EP2006/000161 WO2006077035A1 (en) 2005-01-18 2006-01-11 Peptides with neuropeptide-2 receptor (y2r) agonist activity

Publications (1)

Publication Number Publication Date
NO20073664L true NO20073664L (no) 2007-09-28

Family

ID=36118121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073664A NO20073664L (no) 2005-01-18 2007-07-17 Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet

Country Status (22)

Country Link
US (1) US7410949B2 (zh)
EP (1) EP1844070B1 (zh)
JP (1) JP4633804B2 (zh)
KR (1) KR100905380B1 (zh)
CN (1) CN101107266A (zh)
AR (1) AR051904A1 (zh)
AT (1) ATE500268T1 (zh)
AU (1) AU2006207659B2 (zh)
BR (1) BRPI0606675A2 (zh)
CA (1) CA2594423A1 (zh)
DE (1) DE602006020407D1 (zh)
DK (1) DK1844070T3 (zh)
ES (1) ES2359850T3 (zh)
IL (1) IL184428A0 (zh)
MX (1) MX2007008614A (zh)
NO (1) NO20073664L (zh)
PL (1) PL1844070T3 (zh)
PT (1) PT1844070E (zh)
RU (1) RU2383553C2 (zh)
TW (1) TWI309653B (zh)
WO (1) WO2006077035A1 (zh)
ZA (1) ZA200705674B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007065808A2 (en) * 2005-12-07 2007-06-14 F. Hoffmann-La Roche Ag Neuropeptide-2 receptor-agonists
US8299023B2 (en) * 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
MX2011004427A (es) * 2008-11-05 2011-05-31 Hoffmann La Roche Agonistas del receptor de neuropeptido-2 (y-2r) y usos de los mismos.
WO2011002066A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 ペプチド及びその用途
JP2013505221A (ja) * 2009-09-18 2013-02-14 ノヴォ ノルディスク アー/エス 長時間作用性y2受容体アゴニスト
JP2013507414A (ja) * 2009-10-13 2013-03-04 エフ.ホフマン−ラ ロシュ アーゲー 神経ペプチド−2受容体(y−2r)アゴニスト
RS56998B1 (sr) 2010-12-16 2018-05-31 Novo Nordisk As Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
WO2013139694A1 (en) 2012-03-22 2013-09-26 Novo Nordisk A/S Compositions of glp-1 peptides and preparation thereof
LT2861566T (lt) 2012-06-13 2017-02-10 F. Hoffmann-La Roche Ag Nauji diazaspirocikloalkanai ir azaspirocikloalkanai
CA2878442A1 (en) 2012-09-25 2014-04-03 F. Hoffmann-La Roche Ag Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
US10583172B2 (en) 2013-11-15 2020-03-10 Novo Nordisk A/S HPYY(1-36) having a beta-homoarginine substitution at position 35
CN105722526B (zh) 2013-11-15 2020-12-08 诺和诺德股份有限公司 选择性pyy化合物及其用途
SI3074400T1 (en) 2013-11-26 2018-03-30 F. Hoffmann-La Roche Ag Octahydro-cyclobut (1,2-c, 3,4-cy) dipyrrole derivatives as autoantaxine inhibitors
UA118582C2 (uk) 2014-03-26 2019-02-11 Ф. Хоффманн-Ля Рош Аг Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa)
CN106029667B (zh) 2014-03-26 2019-08-23 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的稠合[1,4]二氮杂*化合物
MA41898A (fr) * 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
KR102476550B1 (ko) 2015-06-12 2022-12-13 노보 노르디스크 에이/에스 선택적인 pyy 화합물 및 그것의 사용
MX2020004504A (es) 2015-09-04 2021-11-10 Hoffmann La Roche Derivados de fenoximetilo.
JP6846414B2 (ja) 2015-09-24 2021-03-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Atx阻害剤としての二環式化合物
BR112018006080A2 (pt) 2015-09-24 2018-10-09 F. Hoffmann-La Roche Ag novos compostos bicíclicos como inibidores de dupla ação de atx/ca
MX2017015034A (es) 2015-09-24 2018-04-13 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
CA2991615A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag Bicyclic compounds as atx inhibitors
WO2018167001A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag Heterocyclic compounds useful as dual atx/ca inhibitors
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
EP3717508A1 (en) 2017-12-01 2020-10-07 The University of Copenhagen Peptide hormone with one or more o-glycans
KR102647171B1 (ko) 2018-02-02 2024-03-15 노보 노르디스크 에이/에스 Glp-1 작용제 및 n-(8-(2-하이드록시벤조일)아미노)카프릴산의 염을 포함하는 고형 조성물
EP3800195A1 (en) * 2019-10-03 2021-04-07 Universitat de Barcelona Peptide compounds for reducing side effects of cb1 receptor agonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
HUT73494A (en) 1993-03-29 1996-08-28 Univ Cincinnati Analogs of peptide yy and uses thereof
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
EP1583549A4 (en) * 2003-01-17 2006-10-04 Sod Conseils Rech Applic YY PEPTIDE ANALOGS
JP2007512365A (ja) * 2003-11-25 2007-05-17 バイエル・フアーマシユーチカルズ・コーポレーシヨン 選択的神経ペプチドy2受容体作動薬
AU2005211776B2 (en) * 2004-02-11 2012-02-02 Amylin Pharmaceuticals, Llc Pancreatic polypeptide family motifs and polypeptides comprising the same

Also Published As

Publication number Publication date
MX2007008614A (es) 2007-09-11
AU2006207659B2 (en) 2009-10-29
ZA200705674B (en) 2009-08-26
WO2006077035A9 (en) 2006-10-26
KR20070095422A (ko) 2007-09-28
ATE500268T1 (de) 2011-03-15
JP2008527017A (ja) 2008-07-24
PT1844070E (pt) 2011-05-04
TW200637874A (en) 2006-11-01
EP1844070A1 (en) 2007-10-17
ES2359850T3 (es) 2011-05-27
AU2006207659A1 (en) 2006-07-27
CN101107266A (zh) 2008-01-16
US7410949B2 (en) 2008-08-12
DK1844070T3 (da) 2011-06-14
BRPI0606675A2 (pt) 2009-07-07
WO2006077035A1 (en) 2006-07-27
EP1844070B1 (en) 2011-03-02
JP4633804B2 (ja) 2011-02-16
DE602006020407D1 (de) 2011-04-14
IL184428A0 (en) 2007-10-31
TWI309653B (en) 2009-05-11
CA2594423A1 (en) 2006-07-27
US20060160742A1 (en) 2006-07-20
KR100905380B1 (ko) 2009-06-30
PL1844070T3 (pl) 2011-07-29
AR051904A1 (es) 2007-02-14
RU2383553C2 (ru) 2010-03-10
RU2007131504A (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
NO20073664L (no) Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
NO20083863L (no) Pyrazoler som 11-beta-hsd-1
NO20074872L (no) Pyrazoler
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
NO20063620L (no) Arylanilinderivater som beta2 adrenergiske receptoragonister
NO20090628L (no) Pyridizinon derivativater
NO20081844L (no) Terapeutiske forbindelser
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
DK1636236T3 (da) Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
GEP20094727B (en) Oxyindole derivatives as 5ht4 receptor agonists
NO20080484L (no) Niacin-reseptorantagonister, preparater inneholdende slike forbindelser og behandlingsmetoder
NO20056132L (no) Krystallinsk form av beta2 adrenergisk receptoragonist
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20076418L (no) Heterocyclic compounds as agonists for the thyroid receptor
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
DE602006018713D1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
NO20085099L (no) Puritonderivativer som HM74A agonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application